Cite

    Jeffrey S Weber et al.. “Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial.” Lancet oncology, vol. 17, no. 7, n.d., pp. 943–955. http://access.bl.uk/ark:/81055/vdc_100033761042.0x00000c